Church – författare

As you should have guessed by the title, this is not the standard bedtime story with a princess and a prince and an evil stepparent and some sort of magic spell. Not one castle, nor trolls, not even an enchanted forest is tucked with loving care into this bedtime story. To be totally honest about the whole shebang, its not so much a bedtime story as a bedtime epic event. An explanation may be in order right about now.There are 30 Adventures in this saga, to be read in order as bedtime stories. No skipping around, mind you, because it will make even less sense if you do that, so when you get to the Temple of the Belchmonkeys and your mind is not totally prepared for it, well, thats a whole different bucket of pickles altogether. And you could rip through more than one story in a night, but that might just make your kids loopy.30 Adventures, 30 nights, so youre pretty much covered for a month. Now, somebodys going to screech that some months have 31 days (thanks, May and October and you other troublemakers for screwing this up) and so you have a day left over. And theres some real hollering going on about the February problem, and how if you read this story during that month, even during a leap year, you still have extra story left over. The thing is, the story is 30 nights long because its a nice round number (unlike 31, which is prime, for crying out loud) and thats how long the story takes to tell. So there.The important idea is that this is an interactive story. Not a passive story where your kid lays there like an unfortunate lump on the mattress and you yammer on until you bore the poor child to sleep. This story has a narrator reading the action lines (thats you, sport). There are also 21 different voices in the tale, all of which youll have fun doing. Even better, let your child read along and read a voice or two. The full list of voices is on the next few pages, plus what we think they sound like, although you can change them pretty much any way you want. Its not like were keeping score.Also, you will find action lines sprinkled throughout. Youll recognize these because theyre in italics so they look like theyre in motion, hence we call them action lines and they instruct you or your offspring to do certain things. Be nice and gentle, since youll have to start a pillow fight in Adventure 1. Remember, youre bigger. Play nice.

For some years, international guidelines on the management of asthma have stressed the importance of early intervention with anti-inflammatory drugs to prevent acute asthma exacerbations and to avert chronic inflammatory damage to the airway. Introduced by a broad survey of the targets for anti-inflammatory drugs, this book proceeds to bring together the most recent research into the mechanisms and clinical benefits of presently available anti-inflammatory treatments including corticosteroids, cromones, and theophylline. For the first time, these drugs are discussed alongside the newly introduced leukotriene modifier drugs, and in the context of frontline research into anti-inflammatory drugs of the future. Leading authorities in their fields evaluate the prospects of novel anti-IgE agents and cytokine antagonists, and examine recent developments in immunosuppressant compounds, protease inhibitors, and selective phosphodiesterase inhibitors. This book is an up-to-date and authoritative survey which will be invaluable to university and pharmaceutical company researchers working on anti-asthma and anti-allergy drugs and to respiratory physicians keeping abreast of developments in their specialty.

For some years, international guidelines on the management of asthma have stressed the importance of early intervention with anti-inflammatory drugs to prevent acute asthma exacerbations and to avert chronic inflammatory damage to the airway. Introduced by a broad survey of the targets for anti-inflammatory drugs, this book proceeds to bring together the most recent research into the mechanisms and clinical benefits of presently available anti-inflammatory treatments including corticosteroids, cromones, and theophylline. For the first time, these drugs are discussed alongside the newly introduced leukotriene modifier drugs, and in the context of frontline research into anti-inflammatory drugs of the future. Leading authorities in their fields evaluate the prospects of novel anti-IgE agents and cytokine antagonists, and examine recent developments in immunosuppressant compounds, protease inhibitors, and selective phosphodiesterase inhibitors. This book is an up-to-date and authoritative survey which will be invaluable to university and pharmaceutical company researchers working on anti-asthma and anti-allergy drugs and to respiratory physicians keeping abreast of developments in their specialty.